BRCA1 and breast cancer: The most common prognostic indicators of breast cancer are BRCA1 mutations, especially for early diagnosis, and they serve as a predictive biomarker for almost 80% of patients with combined ovarian and breast cancer and up to 20% of women with a family history of breast cancer [116].